Monday, June 16, 2014

PROSTATITIS TREATMENT USING I.P.T.




Prostatitis is a very painful medical condition that affects adult men, due to prostate inflammation. The most common cause for prostatitis is due to viral or bacterial infections, there’s an acute and chronic type. The most common symptoms are pain and difficulty urinating, incontinence, painful ejaculations, genital discomfort, urgent frequency to urinate, specially during nighttime, lower back pain, discomfort and burning sensation in the pelvic area.

If not treated effectively, prostatitis can be recurrent and from being acute, may become chronic, developing complications that with time will be longer and harder to treat.

PROSTATITIS TREATMENT USING I.P.T.
A prostatitis treatment using the method I.P.T. and Biological Medicine, offers unique benefits compared to conventional medicine. First, a fine combination of antivirals, antibiotics, antiparasitics and anti inflammatory medicines are selected, these are of natural origin that will not damage your system, potent yet gentler on your body, protecting the immune cells to fight the infection. Depending on the severity of the condition, 6 to 8 treatment sessions are suggested. Patient will notice reduction in pain and inflammation after 2 treatments, it’s painless and there are no adverse effects. Once cured, the patient will receive a follow up and prevention plan, to avoid recurrences.

For an evaluation and budget estimate, please write to: info@iptldmd.com o call our offices:
(Mexico) 52+664+635-1834, (United States) 619-798-8017. Skype: donatopg3

To learn more about I.P.T. for chronic illness and infections, visit:
www.donatoperezgarcia.com o call an I.P.T. Representative today.

No comments:

Post a Comment

Award Presentation to Dr.Donato Perez Garcia, MD during The 14th Annual Conference of the Mexican College of Cellular Therapy and Regenerative Medicine

Mexico City. December 9, 2023. The 14th Annual Conference of the Mexican College of Cellular Therapy and Regenerative Medicine took place. I...